- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02037334
Biomechanics Based Prediction of Preterm Delivery (Softcervix)
December 8, 2022 updated by: David Scheiner
Quantitative information on the biomechanical properties of the ecto-cervix in mid-pregnancy will be compared between women with term vs. preterm delivery.
We aim to demonstrate that biomechanical data (ASP and CCI) might complement morphological data (CL) to improve prediction of preterm delivery.
It is expected that women with preterm delivery will show stronger weakening of cervical tissue.
Aspiration (ASP) and cervical CCI (cervical consistency index) measurements are performed at mid-pregnancy: detection at this time point is useful for therapy and biomechanical modifications are already significant so to enable differentiation by biomechanical measurements (ASP and CCI).
Study Overview
Study Type
Observational
Enrollment (Actual)
1002
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium, 3000
- University Hospital of Leuven
-
-
-
-
-
Aarau, Switzerland
- Kantonsspital Aarau, Frauenklinik
-
Baden, Switzerland
- Kantonsspital Baden, Frauenklinik
-
Basel, Switzerland
- Universitatsspital Basel, Frauenklinik
-
Frauenfeld, Switzerland
- Kantonsspital Frauenfeld, Frauenklinik
-
Genève, Switzerland
- Hopitaux Universitaires de Geneve (HUG)
-
Luzern, Switzerland
- Kantonsspital Luzern, Frauenklinik
-
Münsterlingen, Switzerland
- Kantonsspital Münsterlingen
-
St. Gallen, Switzerland
- Kantonsspital St. Gallen, Klinik für Gynäkologie und Geburtshilfe
-
Winterthur, Switzerland
- Kantonsspital Winterthur
-
Zollikon, Switzerland
- Praxis Zollikon
-
Zurich, Switzerland, 8091
- University Hospital of Zurich, Dept. OB/Gyn
-
Zurich, Switzerland
- Stadtspital Triemli, Frauenklinik
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
All pregnant women at our institutions between 18+0/7 and 22+0/7 weeks of pregnancy and postpartum
Description
Inclusion Criteria:
- All pregnant women presenting at their mid pregnancy consultation (18+0 - 22+0 weeks of pregnancy) are eligible
- Signed informed consent after being informed is a prerequisite for enrollment.
Exclusion Criteria:
- Communication problems
- Missing consent
- Age<18
- Active bleeding / Premature Rupture of Membranes (PROM)
- Active genital infection
- Known carrier of HIV or Hepatitis B or C
- Placenta praevia
- Müllerian anomalies
- known or suspected non-compliance, drug or alcohol abuse
- cerclage
- use of pessary
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pregnancy
|
No intervention is done except for measuring the stiffness of the cervix in pregnant women
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in cervical stiffness in women with/without preterm delivery
Time Frame: Measurements between 18+0/7 and 22+0/7 weeks of pregnancy and postpartum
|
The biomechanical measurements and morphological data obtained at mid-pregnancy are compared between women with/without preterm delivery and are expected to significantly differ.
The diagnostic power for preterm delivery of aspiration, CCI and the other factors will be determined.
|
Measurements between 18+0/7 and 22+0/7 weeks of pregnancy and postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David A Scheiner, MD, University of Zurich
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2014
Primary Completion (Actual)
December 8, 2022
Study Completion (Actual)
December 8, 2022
Study Registration Dates
First Submitted
January 13, 2014
First Submitted That Met QC Criteria
January 14, 2014
First Posted (Estimate)
January 15, 2014
Study Record Updates
Last Update Posted (Estimate)
December 9, 2022
Last Update Submitted That Met QC Criteria
December 8, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KEK-ZH 2013-0244
- 2013-MD-0036 (Other Identifier: Swissmedic)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Delivery
-
Istanbul University - Cerrahpasa (IUC)Kilis 7 Aralik UniversityCompletedPreterm Labor | Preterm Labor with Preterm Delivery in Third Trimester | Preterm Spontaneous Labor with Preterm DeliveryTurkey
-
Instituto de Investigacion Sanitaria La FeWithdrawn
-
University of Modena and Reggio EmiliaCompletedPreterm Labor With Preterm DeliveryItaly
-
Assistance Publique Hopitaux De MarseilleCompletedLow Risk of Preterm DeliveryFrance
-
University of Illinois at ChicagoTerminatedFocus: Prevent Preterm Delivery | Incidental Short Cervix at Mid-trimesterUnited States
-
Ain Shams UniversityRecruitingPreterm Labor With Preterm DeliveryEgypt
-
Ethem Unal, M.D., PhD, Associate Prof of Surgery...UnknownPreterm Birth | Preterm Labor | Preterm Labor Without Delivery | Side Effect of Drug | Preterm Labor With Preterm Delivery in Third Trimester | Calcium-Channel Blockers Toxicity
-
Konya Meram State HospitalRecruitingPregnancy Preterm | Preterm Labor Without DeliveryTurkey
-
University Hospital, Strasbourg, FranceRecruitingPreterm Delivery | Threatened Preterm LaborFrance
-
University of California, San FranciscoCompleted
Clinical Trials on Pregnolia System
-
Pregnolia AGCompletedCervix; PregnancySwitzerland
-
Federico II UniversityRecruiting
-
Pregnolia AGCompleted
-
Tufts Medical CenterPregnolia AGCompletedPreterm Birth | Pregnancy Related | Cervical InsufficiencyUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Pregnolia AGRecruitingPremature Birth | Preterm Birth | Diagnosis | Threatened Preterm Labor | Cervical Incompetence in Pregnancy as Antepartum Condition | Premature Labor | Cervical Incompetence, With DeliveryNetherlands
-
Asklepios proresearchAG PregnoliaRecruiting
-
ResMedCompleted
-
Federal University of São PauloCompletedAdverse Reaction to Systemic AgentsBrazil
-
KineticureCompletedOsteoarthritis | Knee PainUnited States